Intranasal Sufentanyl analgesia Versus Morphine IV in Emergency room.

Authors
Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2015
INTERVENTION: Trade Name: Sufentanil Mylan Product Name: SUFENTANIL Pharmaceutical Form: Nasal spray, solution Pharmaceutical form of the placebo: Solution for injection Route of administration of the placebo: Nasal use Trade Name: Chlorhydrate de Morphine Aguettant Product Name: Chlorhydrate de Morphine Pharmaceutical Form: Solution for injection CONDITION: Therapeutic area: Health Care [N] ‐ Environment and Public Health [N06] PRIMARY OUTCOME: Main Objective: Primary end point(s): Secondary Objective: INCLUSION CRITERIA: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18‐64 years) yes F.1.2.1 Number of subjects for this age range 220 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range
Epistemonikos ID: 814273c1b5718080113259403d039d4ae36769ee
First added on: Aug 23, 2024